Investors

Mole Genetics is a privately held Norwegian biotechnology company founded June 2005. Mole Genetics has benefited by selecting private investors who bring valuable business expertise to the company, in addition to their financial backing.

 
For inquiries concerning investment opportunities or corporate sponsorship, please contact Frank Larsen, CEO/Managing Director at frank.larsen@molegenetics.com (phone: +47 67 10 18 20)